We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$47.8B
AUM Growth
-$11.9B
Cap. Flow
-$13B
Cap. Flow %
-27.21%
Top 10 Hldgs %
6.42%
Holding
4,092
New
858
Increased
1,226
Reduced
1,159
Closed
801

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$6.19B
2
COTY icon
Coty
COTY
+$1.11B
3
AAPL icon
Apple
AAPL
+$294M
4
META icon
Meta Platforms (Facebook)
META
+$229M
5
MSFT icon
Microsoft
MSFT
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 12.19%
2 Financials 11.87%
3 Industrials 10.26%
4 Energy 9.33%
5 Technology 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
3251
Arbutus Biopharma
ABUS
$865M
$47K ﹤0.01%
19,204
-456,918
-96% -$1.33M
LKM
3252
DELISTED
Link Motion Inc.
LKM
$47K ﹤0.01%
14,500
-295,891
-95% -$1.03M
VNCE icon
3253
Vince Holding Corp
VNCE
$76.2M
$46K ﹤0.01%
+1,142
New +$54.4K
LTS
3254
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$46K ﹤0.01%
18,678
-27,607
-60% -$64.2K
IMN
3255
DELISTED
Imation
IMN
$46K ﹤0.01%
56,019
-40,073
-42% -$30K
SOL
3256
DELISTED
Emeren Group
SOL
$45K ﹤0.01%
+13,968
New +$58K
DSX icon
3257
Diana Shipping
DSX
$280M
$39K ﹤0.01%
+18,375
New +$37.6K
DFBG
3258
DELISTED
Differential Brands Group Inc
DFBG
$39K ﹤0.01%
16,639
-19,911
-54% -$71.4K
ALIM
3259
DELISTED
Alimera Sciences
ALIM
$37K ﹤0.01%
2,297
-4,776
-68% -$87.4K
CALA
3260
DELISTED
Calithera Biosciences, Inc
CALA
$37K ﹤0.01%
576
-4,538
-89% -$283K
GALTW
3261
DELISTED
Galectin Therapeutics Inc. - Warrants
GALTW
$35K ﹤0.01%
640,800
ONSIZ
3262
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$33K ﹤0.01%
42,224
-1,170
-3% -$901
OPXAW
3263
DELISTED
Opexa Therapeutics, Inc.
OPXAW
$32K ﹤0.01%
1,600,000
PZG icon
3264
Paramount Gold Nevada
PZG
$94.4M
$29K ﹤0.01%
+16,356
New +$28.5K
CETV
3265
DELISTED
Central European Media Enterprises Ltd
CETV
$28K ﹤0.01%
+10,800
New +$27.1K
OREX
3266
DELISTED
Orexigen Therapeutics, Inc.
OREX
$28K ﹤0.01%
15,823
-25,912
-62% -$60.9K
AGFSW
3267
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$27K ﹤0.01%
150,000
ARDM
3268
DELISTED
Aradigm Corp Common Stock
ARDM
$26K ﹤0.01%
+16,474
New +$72.2K
BIOL
3269
DELISTED
Biolase, Inc.
BIOL
$25K ﹤0.01%
+1
New +$19.8K
CYTO
3270
DELISTED
Altamira Therapeutics Ltd
CYTO
0
ELDN icon
3271
Eledon Pharmaceuticals
ELDN
$276M
$22K ﹤0.01%
142
+64
+82% +$12.3K
UAMY icon
3272
United States Antimony
UAMY
$766M
$17K ﹤0.01%
69,521
-50,495
-42% -$17.9K
ENSV
3273
DELISTED
Enservco Corp.
ENSV
$16K ﹤0.01%
+1,950
New +$16.3K
ACER
3274
DELISTED
Acer Therapeutics Inc
ACER
$15K ﹤0.01%
+1,520
New +$26.6K
ASM
3275
Avino Silver & Gold Mines
ASM
$987M
$14K ﹤0.01%
+10,546
New +$18K

Similar funds

Millennium Management's Q4 2016 Portfolio in Review

As of Q4 2016, Millennium Management held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Millennium Management withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.

Against the trend, Millennium Management opened a new position in Target worth $175M.

  • Millennium Management's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
  • Millennium Management added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
  • Millennium Management's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
  • Millennium Management fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
  • Millennium Management's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
  • Millennium Management opened 858 new positions and closed 801 in Q4 2016.
  • Millennium Management's portfolio value fell 20% quarter-over-quarter to $47.8B.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.